Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV10 Priming Schedule Comparison in Nepali Children
NCT02385513Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Aug 2015
- Primary completion
- Jan 2017
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection (2 arms), sponsored by University of Oxford. Primary endpoint: Proportion of infants with serotype specific IgG >= 0.35 ug/mL against pneumococcal vaccine serotypes at 9 months. Started Aug 2015; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02385513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385513.